Medical marijuana use in Connecticut

Aliya C. Roginiel, Anand D. Gopal, Ravi Parikh, Joseph S. Ross, Lucian V. Del Priore, Christopher C. Teng

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The Connecticut Medical Marijuana Program (MMP) was approved in 2012, allowing for the legal use of marijuana under specific indications. Tis study describes the use of medical marijuana in CT, using data as of May 2017. Methods: Data were gathered from the CT MMP. We characterized medical marijuana use by county, by indication, and by physician certification of registrants for medical marijuana. Results: Medical marijuana registrants comprised 0.5% (N = 18 118/3 590 886) of the CT population. The most frequent indications for medical marijuana were posttraumatic stress disorder (PTSD) (41.4%, N = 7503/18 118) and damage to the spinal cord with indication of intractable spasticity (20.2%, N = 3668/18 118). A small percentage (4.9%, N = 689/14 138) of CT physicians were registered to certify patients. Conclusion: Medical marijuana registrants made up less than 1% of the CT population. Few physicians were registered to certify patients. Over half of registrants used marijuana for PTSD or for damage to the spinal cord with indication of intractable spasticity.

Original languageEnglish
Pages (from-to)69-74
Number of pages6
JournalConnecticut Medicine
Volume82
Issue number2
StatePublished - Feb 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Medical marijuana use in Connecticut'. Together they form a unique fingerprint.

Cite this